Search Results - David J. Hunter

David Hunter (epidemiologist)

David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in the Department of Epidemiology and the Department of Nutrition of Harvard University. He was associate epidemiologist at the Channing Laboratory, Brigham and Women's Hospital, where he was involved with the programs in breast cancer, cancer epidemiology, and cancer genetics research teams.

Hunter directs the Translational Epidemiology Unit (TEU) at Oxford Population Health, and leads a collaborative project between Oxford and the Harvard T.H. Chan School of Public Health. Provided by Wikipedia
  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Establishing the natural history and growth rate of ameloblastoma with implications for management: systematic review and meta-analysis. by Michael P Chae, Nicolas R Smoll, David J Hunter-Smith, David J Hunter-Smith, Warren Matthew Rozen

    Published 2015-01-01

    <h4>Background</h4>Ameloblastoma is the second most common odontogenic tumor, known to be slow-growing, persistent, and locally aggressive. Recent data suggests that ameloblastoma is best treated with wide resection and adequate margins. Following primary excision, bony reconstruction is...

    Full description

    Get full text
    Article
  2. 2

    Intra-articular injections for knee osteoarthritis management: Analysis of cost-effectiveness by Hanna Mass, Jamie E. Collins, Catherine Yang, David J. Hunter, Morgan H. Jones, Love Tsai, Stephen P. Messier, Tuhina Neogi, Jeffrey N. Katz, Elena Losina

    Published 2025-09-01

    Objective: Intra-articular injections (IAI) are commonly used to treat knee pain in persons with knee osteoarthritis (OA). We sought to determine the value of commonly used IAIs in knee OA management. Methods: We used the validated Osteoarthritis Policy Model (OAPol) to assess the value of saline, c...

    Full description

    Get full text
    Article
  3. 3
  4. 4

    GWAS meta-analysis identifies five susceptibility loci for endometrial cancerResearch in context by Dhanya Ramachandran, Xuemin Wang, Triin Laisk, Ying Zheng, Nathan Ingold, Daffodil M. Canson, Pik Fang Kho, Bianca J. Naumann, Carly J. Chapman, Kristine Bousset, Anna V. Krause, Peter Schürmann, Britta Wieland, Patricia Hanel, Fabienne Hülse, Norman Häfner, Ingo Runnebaum, Natalia Dubrowinskaja, Nurzhan Turmanov, Tatyana Yugay, Zura Berkutovna Yessimsiitova, Frédéric Amant, Daniela Annibali, Matthias W. Beckmann, Clara Bodelon, Daniel D. Buchanan, Chu Chen, Megan A. Clarke, Linda S. Cook, Immaculata De Vivo, Wout De Wispelaere, Mengmeng Du, Douglas F. Easton, Julius Emons, Peter A. Fasching, Christine M. Friedenreich, Grace Gallagher, Graham G. Giles, Ellen L. Goode, Holly R. Harris, David J. Hunter, David L. Kolin, Peter Kraft, James V. Lacey, Diether Lambrechts, Lingeng Lu, George L. Mutter, Jeffin Naduparambil, Kelli O’Connell, Alpa V. Patel, Paul D.P. Pharoah, Timothy R. Rebbeck, Fulvio Ricceri, Harvey A. Risch, Matthias Ruebner, Carlotta Sacerdote, Rodney J. Scott, V. Wendy Setiawan, Xiao-Ou Shu, Melissa C. Southey, Emma Tham, Ian Tomlinson, Constance Turman, Nicolas Wentzensen, Wanghong Xu, Herbert Yu, Wei Zheng, Amanda B. Spurdle, Yosef Yarden, Reedik Mägi, Peter Hillemanns, Dylan M. Glubb, Thilo Dörk, Tracy A. O’Mara

    Published 2025-08-01

    Summary: Background: Endometrial cancer is the most common gynaecological cancer in high-income countries. In addition to environmental risk factors, genetic predisposition contributes towards endometrial cancer development but is still incompletely defined. Methods: Building on genome-wide associa...

    Full description

    Get full text
    Article